Pay in 4 interest-free payments of $7.17 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Novo Nordisk and Eli Lilly are setting a precedent and if it pays off then we can expect that other pharmaceutical companies will follow suit
Patients should understand financial implications and that treatment costs will be out-of-pocket expenses
An update on adaptive deep brain stimulation in Parkinsons disease
Activation of GLP-1R signaling promotes M2-like macrophage phenotype while inhibiting M1-like macrophages across various models
10.1038/364247a0 108 MauchF.DudlerR
US$ 27.34
US$ 29.84
US$ 20.64
US$ 22.32
US$ 21.86
US$ 21.38
US$ 21.76
US$ 22.17
US$ 22.57
